These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 20810248)

  • 41. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
    Zeggar S; Watanabe KS; Teshigawara S; Hiramatsu S; Katsuyama T; Katsuyama E; Watanabe H; Matsumoto Y; Kawabata T; Sada KE; Niki T; Hirashima M; Wada J
    Arthritis Rheumatol; 2018 Jul; 70(7):1089-1101. PubMed ID: 29481735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney.
    Zhang JL; Sun DJ; Hou CM; Wei YL; Li XY; Yu ZY; Feng JN; Shen BF; Li Y; Xiao H
    Transpl Immunol; 2010 Oct; 24(1):17-25. PubMed ID: 20850528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus.
    Satoh M; Mizutani A; Behney KM; Kuroda Y; Akaogi J; Yoshida H; Nacionales DC; Hirakata M; Ono N; Reeves WH
    Int Immunol; 2003 Sep; 15(9):1117-24. PubMed ID: 12917264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.
    Lech M; Kantner C; Kulkarni OP; Ryu M; Vlasova E; Heesemann J; Anz D; Endres S; Kobayashi KS; Flavell RA; Martin J; Anders HJ
    Ann Rheum Dis; 2011 Dec; 70(12):2207-17. PubMed ID: 21875872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
    Alleva DG; Kaser SB; Beller DI
    J Immunol; 1998 Dec; 161(12):6878-84. PubMed ID: 9862720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels.
    Maeda T; Nomoto K
    J Rheumatol; 1995 Dec; 22(12):2259-65. PubMed ID: 8835559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD19 hyperexpression augments Sle1-induced humoral autoimmunity but not clinical nephritis.
    Shi X; Xie C; Chang S; Zhou XJ; Tedder T; Mohan C
    Arthritis Rheum; 2007 Sep; 56(9):3057-69. PubMed ID: 17763445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Susceptibility of mast cell-deficient W/Wv mice to pristane-induced experimental lupus nephritis.
    Lin L; Gerth AJ; Peng SL
    Immunol Lett; 2004 Feb; 91(2-3):93-7. PubMed ID: 15019275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. B cell apoptosis accelerates the onset of murine lupus.
    Trébéden-Nègre H; Weill B; Fournier C; Batteux F
    Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Caspase-1 is required for maintenance of marginal zone B cells in pristane-induced lupus.
    Morse MD; Clark KL; Cascalho M; Kahlenberg JM
    Lupus; 2016 Jan; 25(1):81-7. PubMed ID: 26405027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice.
    Liu C; Kanamaru Y; Watanabe T; Tada N; Horikoshi S; Suzuki Y; Liu Z; Tomino Y
    Clin Exp Immunol; 2015 Sep; 181(3):407-16. PubMed ID: 25907714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane.
    Richards HB; Satoh M; Jennette JC; Croker BP; Yoshida H; Reeves WH
    Kidney Int; 2001 Dec; 60(6):2173-80. PubMed ID: 11737591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study on experimental systemic lupus erythematosus mouse model induced by pristane].
    Li JZ; Ding J; Merim B; Li HW; Zhang Y; Shen H; Chen XJ; Wang SJ; Wang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Feb; 27(2):119-22. PubMed ID: 21315035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage.
    Bagavant H; Deshmukh US; Gaskin F; Fu SM
    Scand J Immunol; 2004; 60(1-2):52-63. PubMed ID: 15238073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage.
    Huang W; Wu J; Yang H; Xiong Y; Jiang R; Cui T; Ye D
    Cell Death Differ; 2017 Feb; 24(2):263-275. PubMed ID: 27768123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenesis of lupus-like nephritis through autoimmune antibody produced by CD180-negative B lymphocytes in NZBWF1 mouse.
    Fujita K; Akasaka Y; Kuwabara T; Wang B; Tanaka K; Kamata I; Yokoo T; Kinoshita T; Iuchi A; Akishima-Fukasawa Y; Ishikawa Y; Kondo M; Ishii T
    Immunol Lett; 2012 May; 144(1-2):1-6. PubMed ID: 22387632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunopathogenesis of lupus nephritis: new insights from experimental models.
    Izui S
    Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):610-5. PubMed ID: 8583696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.